GS-US-321-0102: A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, Monoclonal
Name
Gilead Sciences, Incorporated
Anticipated Amount
255 057.00
Activity Type
Clinical Trial
Award Type
Contract
Date
August 1, 2012 to August 30, 2014
Award Number
006283-00001
Sponsor Award Number
GS-US-321-0102
Award Contacts
Name
Boyer,Thomas D
Title
Principal Investigator
Unit
Liver Research Institute